Market By Drugs & Devices And Geography | Forecast 2019-2027
The Triton Market Research report on the global ophthalmology drugs and devices market depicts that the market will display an upward trend in terms of revenue and is estimated to flourish with CAGR of 6.16% over the forecasting years of 2019-2027. The market was assessed to be worth $61957.65 million in the year 2018 and is predicted to generate a revenue of approximately $106099.61 million by the year 2027.
Report scope can be customized per your requirements. Request For Customization
Ophthalmology is a field of medicine dealing with the anatomy, physiology and diseases of the eyeball and the orbit. An ophthalmologist is a specialist doctor who treats medical and surgical eye-related conditions. Ophthalmology also includes sub-specialities that deal either with certain sickness as a whole or diseases concerning certain parts of the eye.
Within the Triton report, the study of the market has been detailed by highlighting it within the key components for a clear understanding of every aspect that influences the global market. The report consists of a strategic outlook, key insights, value chain outlook, key buying standards, investment outlook, supply chain outlook, regulatory outlook and Porter’s five force analysis.
The market drivers like increasing elderly population, surge in ophthalmic disorders due to high blood sugar, rise in healthcare spending and other technological advancements are responsible for boosting the market ahead. On the other hand, expirations of brand patents, which affect the pharmaceutical industry, low cognizance related to ophthalmic drugs and delay in drug approval are known to obstruct the industry growth significantly.
Key opportunities such as the increasing demand for phacoemulsification devices and intraocular lenses and the rising opportunities for these drugs from the emerging countries are set to leverage the growth prospects for the market over the projected years. Still, challenges such as difficulties associated with the conduct of ocular diseases remain unsolved, which threatens the further growth of the market.
To get detailed insights on segments, Download Sample Report
The prime geographies that have been covered in the Triton’s ophthalmology drugs and devices market are:
• North America: The United States and Canada
• Europe: The United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia-Pacific
• Latin America: Brazil, Mexico and Rest of Latin America
• The Middle East and Africa: The United Arab Emirates, Turkey, Saudi Arabia, South Africa and Rest of the Middle East & Africa
Global ophthalmology drugs and devices market segmentation:
The ophthalmology drugs and devices market report has been segmented into drugs and devices.
• Devices:
O Diagnostic and Monitoring Equipment
• Optical Coherence Tomography
• Ophthalmic Ultrasound Imaging Systems
• Fundus Camera Market
• Ophthalmoscope
• Retinoscope
• Pachymeter
• Wavefront Aberrometers
• Perimeters/Visual Field Analyzer
• Autorefractors/Phoropter
• Specular Microscope
• Corneal Topographers
• Other Diagnostic and Monitoring Equipment
O Surgery Devices
• Cataract Surgery Devices
• Glaucoma Surgery Devices
• Refractive Surgery Devices
• Vitreoretinal Surgery Devices
O Vision Care
• Drugs:
O Glaucoma Drug
O Retinal Disorder Drug
O Dry Eye Drug
O Allergic Conjunctivitis, Inflammation And Conjunctivitis Drug
O Drugs by use of Preservation
• Preserved Drugs
• Preservative-free Drugs
The major players in the ophthalmology drugs and devices market are Allergan, Inc., Bayer, Carl Zeiss AG, Essilor International S.A., GlaxoSmithKline, Johnson & Johnson, Inc., Novartis International AG, Pfizer, Roche Holding AG, Santen Pharmaceutical Co., Ltd., Sun Pharmaceuticals Industries, Ltd., Valeant Pharmaceuticals International, Inc. and Ziemer Group Holding AG.
Each of these companies has been studied in detail for the ophthalmology drugs and devices market report. The market share of the above-mentioned companies is detailed in the competitive analysis chapter to provide information about the market positioning and to determine their hold on the market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1.
GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES ANALYSIS
2.2.1.
BARGAINING POWER OF BUYERS
2.2.2.
BARGAINING POWER OF SUPPLIER
2.2.3.
THREATS OF NEW ENTRANTS
2.2.4.
THREATS OF SUBSTITUTES
2.2.5.
COMPETITIVE RIVALRY
2.3. STRATEGIC OUTLOOK
2.4. MARKET SHARE OUTLOOK
2.5. KEY INSIGHT
2.6. VALUE CHAIN OUTLOOK
2.7. KEY BUYING STANDARDS
2.8. INVESTMENT OUTLOOK
2.9. SUPPLY CHAIN OUTLOOK
2.10.
REGULATORY FRAMEWORK
2.11.
MARKET DRIVERS
2.11.1.
ELDERLY POPULATION IS INCREASING WORLDWIDE
2.11.2.
INCREASING OPHTHALMIC DISORDERS DUE TO HIGH BLOOD SUGAR
2.11.3.
UPSURGE IN HEALTHCARE SPENDING
2.11.4.
TECHNOLOGICAL ADVANCEMENT
2.12.
MARKET RESTRAINTS
2.12.1.
EXPIRATIONS OF BRAND PATENTS HAVE AFFECTED THE PHARMACEUTICAL INDUSTRY
2.12.2.
LOW COGNIZANCE RELATED TO OPHTHALMIC DRUGS
2.12.3.
DRUG APPROVALS DELAY AND NUMBER OF DRUGS IN THE PIPELINE
2.13.
MARKET OPPORTUNITIES
2.13.1.
INCREASING DEMAND FOR PHACOEMULSIFICATION DEVICES AND INTRAOCULAR LENSES
2.13.2.
RISING OPPORTUNITIES IN THE DEVELOPING COUNTRIES
2.14.
MARKET CHALLENGES
2.14.1.
DIFFICULTIES ASSOCIATED WITH THE CONDUCT OF OCULAR DISEASES
3.
OPTHALMOLOGY DRUGS AND DEVICES MARKET OUTLOOK - BY DRUGS AND DEVICES
3.1. DEVICES
3.1.1.
DIAGNOSTIC & MONITORING EQUIPMENT
3.1.1.1.
OPTICAL COHERENCE TOMOGRAPHY
3.1.1.2.
OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
3.1.1.3.
FUNDUS CAMERA MARKET
3.1.1.4.
OPHTHALMOSCOPES
3.1.1.5.
RETINOSCOPE
3.1.1.6.
PACHYMETER
3.1.1.7.
WAVEFRONT ABERROMETERS
3.1.1.8.
PERIMETERS/VISUAL FIELD ANALYZER
3.1.1.9.
AUTOREFRACTORS/PHOROPTER
3.1.1.10.
SPECULAR MICROSCOPE
3.1.1.11.
CORNEAL TOPOGRAPHERS
3.1.1.12.
OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET
3.1.2.
SURGERY DEVICE
3.1.2.1.
CATARACT SURGERY DEVICES
3.1.2.2.
GLAUCOMA SURGERY DEVICES
3.1.2.3.
REFRACTIVE SURGERY DEVICES
3.1.2.4.
VITREORETINAL SURGERY DEVICES
3.1.3.
VISION CARE
3.2. DRUGS
3.2.1.
GLAUCOMA DRUG
3.2.2.
RETINAL DISORDER DRUG
3.2.3.
DRY EYE DRUG
3.2.4.
ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG
3.2.5.
DRUGS BY USE OF PRESERVATION
3.2.5.1.
PRESERVED DRUGS
3.2.5.2.
PRESERVATIVE-FREE DRUGS
4.
OPTHALMOLOGY DRUGS AND DEVICES MARKET - REGIONAL OUTLOOK
4.1. NORTH AMERICA
4.1.1.
MARKET BY DRUGS AND DEVICES
4.1.1.1.
MARKET BY DEVICES
4.1.1.2.
MARKET BY DRUGS
4.1.2.
COUNTRY ANALYSIS
4.1.2.1.
THE UNITED STATES
4.1.2.2.
CANADA
4.2. EUROPE
4.2.1.
MARKET BY DRUGS AND DEVICES
4.2.1.1.
MARKET BY DEVICES
4.2.1.2.
MARKET BY DRUGS
4.2.2.
COUNTRY ANALYSIS
4.2.2.1.
THE UNITED KINGDOM
4.2.2.2.
FRANCE
4.2.2.3.
GERMANY
4.2.2.4.
SPAIN
4.2.2.5.
ITALY
4.2.2.6.
RUSSIA
4.2.2.7.
REST OF EUROPE
4.3. ASIA-PACIFIC
4.3.1.
MARKET BY DRUGS AND DEVICES
4.3.1.1.
MARKET BY DEVICES
4.3.1.2.
MARKET BY DRUGS
4.3.2.
COUNTRY ANALYSIS
4.3.2.1.
INDIA
4.3.2.2.
CHINA
4.3.2.3.
JAPAN
4.3.2.4.
SOUTH KOREA
4.3.2.5.
AUSTRALIA & NEW ZEALAND
4.3.2.6.
ASEAN COUNTRIES
4.3.2.7.
REST OF APAC
4.4. LATIN AMERICA
4.4.1.
MARKET BY DRUGS AND DEVICES
4.4.1.1.
MARKET BY DEVICES
4.4.1.2.
MARKET BY DRUGS
4.4.2.
COUNTRY ANALYSIS
4.4.2.1.
BRAZIL
4.4.2.2.
MEXICO
4.4.2.3.
REST OF LATIN AMERICA
4.5. MIDDLE EAST AND AFRICA
4.5.1.
MARKET BY DRUGS AND DEVICES
4.5.1.1.
MARKET BY DEVICES
4.5.1.2.
MARKET BY DRUGS
4.5.2.
COUNTRY ANALYSIS
4.5.2.1.
SAUDI ARABIA
4.5.2.2.
TURKEY
4.5.2.3.
UNITED ARAB EMIRATES
4.5.2.4.
SOUTH AFRICA
4.5.2.5.
REST OF MIDDLE EAST & AFRICA
5.
COMPETITIVE LANDSCAPE
5.1. ALLERGAN, INC.
5.2. BAYER
5.3. CARL ZEISS AG
5.4. ESSILOR INTERNATIONAL S.A.
5.5. GLAXOSMITHKLINE
5.6. JOHNSON & JOHNSON, INC.
5.7. NOVARTIS INTERNATIONAL AG
5.8. PFIZER
5.9. ROCHE HOLDING AG
5.10.
SANTEN PHARMACEUTICAL CO., LTD.
5.11.
SUN PHARMACEUTICALS INDUSTRIES, LTD.
5.12.
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
5.13.
ZIEMER GROUP HOLDING AG
6.
METHODOLOGY AND SCOPE
6.1. RESEARCH SCOPE
6.2. SOURCES OF DATA
6.3. RESEARCH METHODOLOGY
TABLE LIST
TABLE 1 GLOBAL OPHTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 2 COMMON CAUSES OF
LOSS OF VISION IN THE ELDERLY
TABLE 3 SELECTED LIST OF
GLAUCOMA DRUGS IN LATE-STAGE CLINICAL TRIALS
TABLE 4 EYE DRUGS GONE
OFF-PATENT
TABLE 5 GLOBAL OPHTHALMOLOGY
DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 6 GLOBAL DEVICES
MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT BY TYPES 2019-2027 ($ MILLION)
TABLE 7 GLOBAL DEVICES
MARKET IN SURGERY DEVICE BY TYPES 2019-2027 ($ MILLION)
TABLE 8 GLOBAL DRUGS AND
DEVICES MARKET IN DRUGS BY TYPES 2019-2027 ($ MILLION)
TABLE 9 GLOBAL DRUGS MARKET
IN DRUGS BY USE OF PRESERVATION 2019-2027 ($ MILLION)
TABLE 10 GLOBAL DRUGS BY USE
OF PRESERVATION IN PRESERVATIVE FREE DRUGS BY DOSES 2019-2027 ($ MILLION)
TABLE 11 GLOBAL DRUGS BY USE
OF PRESERVATION IN PRESERVATIVE-FREE DRUGS 2019-2027 ($ MILLION)
TABLE 12 GLOBAL OPHTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA
OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($
MILLION)
TABLE 14 NORTH AMERICA
OPTHALMOLOGY DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)
TABLE 15 EUROPE OPHTHALMOLOGY
DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 16 EUROPE OPTHALMOLOGY
DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)
TABLE 17 ASIA-PACIFIC
OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($
MILLION)
TABLE 18 ASIA-PACIFIC
OPTHALMOLOGY DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)
TABLE 19 LATIN AMERICA
OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($
MILLION)
TABLE 20 LATIN AMERICA
OPTHALMOLOGY DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)
TABLE 21 MIDDLE EAST AND
AFRICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($
MILLION)
TABLE 22 MIDDLE EAST AND
AFRICA OPTHALMOLOGY DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)
FIGURE 1 GLOBAL OPTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 2 GLOBAL OPHTHALMOLOGY
DEVICES COMPANY MARKET SHARE 2018 (%)
FIGURE 3 GLOBAL OPHTHALMOLOGY
DRUGS COMPANY MARKET SHARE 2018 (%)
FIGURE 4 THE POPULATION OF
PEOPLE AGED 65 AND OVER WILL DOUBLE IN THE NEXT 25 YEARS (IN MILLION)
FIGURE 5 PROJECTIONS FOR THE
PROPORTION OF GERIATRIC (60+) POPULATION IN 2015, 2030 & 2050
FIGURE 6 PREVALENCE OF DIABETES
BY AGE GROUP (IN MILLION)
FIGURE 7 GLOBAL DRUGS AND
DEVICES MARKET IN DEVICES 2019-2027 ($ MILLION)
FIGURE 8 GLOBAL DEVICES MARKET
IN DIAGNOSTIC & MONITORING EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 9 GLOBAL DIAGNOSTIC
& MONITORING EQUIPMENT MARKET IN OPTICAL COHERENCE TOMOGRAPHY 2019-2027 ($
MILLION)
FIGURE 10 GLOBAL DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 2019-2027
($ MILLION)
FIGURE 11 GLOBAL DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN FUNDUS CAMERA MARKET 2019-2027 ($ MILLION)
FIGURE 12 GLOBAL DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN OPHTHALMOSCOPES 2019-2027 ($ MILLION)
FIGURE 13 GLOBAL DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN RETINOSCOPE 2019-2027 ($ MILLION)
FIGURE 14 GLOBAL DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN PACHYMETER 2019-2027 ($ MILLION)
FIGURE 15 GLOBAL DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN WAVEFRONT ABERROMETERS 2019-2027 ($ MILLION)
FIGURE 16 GLOBAL DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN PERIMETERS/VISUAL FIELD ANALYZER 2019-2027 ($
MILLION)
FIGURE 17 GLOBAL DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN AUTOREFRACTORS/PHOROPTER 2019-2027 ($ MILLION)
FIGURE 18 GLOBAL DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN SPECULAR MICROSCOPE 2019-2027 ($ MILLION)
FIGURE 19 GLOBAL DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN CORNEAL TOPOGRAPHERS 2019-2027 ($ MILLION)
FIGURE 20 GLOBAL DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN OTHER DIAGNOSTIC & MONITORING EQUIPMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 21 GLOBAL DEVICES MARKET
IN SURGERY DEVICE 2019-2027 ($ MILLION)
FIGURE 22 GLOBAL SURGERY DEVICES
MARKET IN CATARACT SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 23 GLOBAL SURGERY DEVICES
MARKET IN GLAUCOMA SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 24 GLOBAL SURGERY DEVICES
MARKET IN REFRACTIVE SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 25 GLOBAL SURGERY DEVICES
MARKET IN VITREORETINAL SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 26 GLOBAL DEVICES MARKET
IN VISION CARE MARKET 2019-2027 ($ MILLION)
FIGURE 27 GLOBAL DRUGS AND
DEVICES MARKET IN DRUGS 2019-2027 ($ MILLION)
FIGURE 28 GLOBAL DRUGS MARKET IN
GLAUCOMA DRUG 2019-2027 ($ MILLION)
FIGURE 29 GLOBAL DRUGS MARKET IN
RETINAL DISORDER DRUG 2019-2027 ($ MILLION)
FIGURE 30 GLOBAL DRUGS MARKET IN
DRY EYE DRUG 2019-2027 ($ MILLION)
FIGURE 31 GLOBAL DRUGS MARKET IN
ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2019-2027 ($
MILLION)
FIGURE 32 GLOBAL DRUGS BY USE OF
PRESERVATION IN PRESERVED DRUGS 2019-2027 ($ MILLION)
FIGURE 33 GLOBAL DRUGS BY USE OF
PRESERVATION IN PRESERVATIVE-FREE DRUGS 2019-2027 ($ MILLION)
FIGURE 34 GLOBAL
PRESERVATIVE-FREE DRUGS MARKET IN SINGLE-DOSE 2019-2027 ($ MILLION)
FIGURE 35 GLOBAL
PRESERVATIVE-FREE DRUGS MARKET IN MULTI-DOSE 2019-2027 ($ MILLION)
FIGURE 36 NORTH AMERICA
OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 37 THE UNITED STATES
OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 38 CANADA OPTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 39 EUROPE OPTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 40 THE UNITED KINGDOM
OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 41 FRANCE OPTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 42 GERMANY OPTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 43 SPAIN OPTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 44 ITALY OPTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 45 RUSSIA OPTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 46 REST OF EUROPE
OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 47 ASIA-PACIFIC
OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 48 INDIA OPTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 49 CHINA OPTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 50 JAPAN OPTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 51 SOUTH KOREA
OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 52 AUSTRALIA & NEW
ZEALAND OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 53 ASEAN COUNTRIES
OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 54 REST OF APAC
OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 55 BRAZIL OPTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 56 MEXICO OPTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 57 REST OF LATIN AMERICA
COUNTRIES OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 58 SAUDI ARABIA COUNTRIES
OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 59 TURKEY COUNTRIES
OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 60 THE UNITED ARAB
EMIRATES COUNTRIES OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 61 SOUTH AFRICA COUNTRIES
OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 62 REST
OF MIDDLE EAST & AFRICA COUNTRIES OPTHALMOLOGY DRUGS AND DEVICES MARKET
2019-2027 ($ MILLION)